Welltower Inc. $WELL Stock Position Lowered by M.D. Sass LLC

M.D. Sass LLC reduced its holdings in shares of Welltower Inc. (NYSE:WELL) by 23.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 326,832 shares of the real estate investment trust’s stock after selling 97,756 shares during the quarter. Welltower makes up 4.7% of M.D. Sass LLC’s investment portfolio, making the stock its 8th largest position. M.D. Sass LLC’s holdings in Welltower were worth $58,222,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Global Wealth Strategies & Associates purchased a new stake in Welltower in the 3rd quarter valued at approximately $36,000. Newbridge Financial Services Group Inc. lifted its position in shares of Welltower by 39.5% in the second quarter. Newbridge Financial Services Group Inc. now owns 307 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 87 shares in the last quarter. Copia Wealth Management acquired a new stake in shares of Welltower during the second quarter valued at $51,000. City Holding Co. purchased a new stake in Welltower during the 3rd quarter worth about $59,000. Finally, Salomon & Ludwin LLC acquired a new position in Welltower in the 3rd quarter valued at about $59,000. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on WELL shares. Scotiabank raised their target price on shares of Welltower from $182.00 to $214.00 and gave the stock a “sector outperform” rating in a research report on Thursday, November 13th. Wells Fargo & Company upped their target price on Welltower from $200.00 to $218.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $205.00 price target on shares of Welltower in a report on Thursday, December 18th. National Bankshares set a $246.00 price objective on shares of Welltower in a research note on Friday, October 17th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Welltower in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $204.80.

Welltower Stock Up 3.1%

Shares of NYSE:WELL opened at $191.16 on Friday. The stock has a market capitalization of $131.20 billion, a P/E ratio of 131.83, a PEG ratio of 1.29 and a beta of 0.85. The company has a debt-to-equity ratio of 0.43, a quick ratio of 5.47 and a current ratio of 5.47. Welltower Inc. has a 1 year low of $130.29 and a 1 year high of $209.05. The stock has a 50-day simple moving average of $189.58 and a 200-day simple moving average of $179.73.

Welltower Company Profile

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.